| Dr Robert D Wallace, MD | |
|
1068 Cresthaven Rd Ste 500, Memphis, TN 38119 | |
| (901) 866-8525 | |
| Not Available |
| Full Name | Dr Robert D Wallace |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 40 Years |
| Location | 1068 Cresthaven Rd Ste 500, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023075637 | NPI | - | NPPES |
| 130322001 | Medicaid | AR | |
| 00118676 | Medicaid | MS | |
| 3804973 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 27658 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Memorial Hospital | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wallace Plastic Surgery Group, Pllc | 0749664076 | 2 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Left ventricular assist devices, or LVADs, have been shown to help leaky mitral valves that create significant regurgitation, but a new study questions the presumption that all's well with the mitral valve after a patient receives a LVAD.
"During the recent International XIX International AIDS Conference (AIDS 2012) in Washington, D.C., exciting breakthroughs in HIV prevention, treatment, and care - even a possible cure - took center stage," but, "despite recent advances, many men and women remain at risk of HIV as a result of structural issues that fuel and have an impact on the epidemic," Molly Fitzgerald, technical advisor for AIDSTAR-One, writes in this post in USAID's "Impact Blog."
FEI is pleased to announce that researchers at the NIH-FEI Living Lab for Structural Biology have achieved breakthrough biological results, using FEI's Titan Krios™ transmission electron microscope (TEM), to elucidate the structural mechanism by which glutamate receptors participate in the transmission of signals between neurons in the brain. Their work is described in Nature, "Structural Mechanism of Glutamate Receptor Activation and Desensitization," by Meyerson, et al., (DOI: 10.1038/nature13603), http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13603.html .
› Verified 9 days ago
| Entity Name | Ut Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780676650 PECOS PAC ID: 3173435369 Enrollment ID: O20031105000384 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Left ventricular assist devices, or LVADs, have been shown to help leaky mitral valves that create significant regurgitation, but a new study questions the presumption that all's well with the mitral valve after a patient receives a LVAD.
"During the recent International XIX International AIDS Conference (AIDS 2012) in Washington, D.C., exciting breakthroughs in HIV prevention, treatment, and care - even a possible cure - took center stage," but, "despite recent advances, many men and women remain at risk of HIV as a result of structural issues that fuel and have an impact on the epidemic," Molly Fitzgerald, technical advisor for AIDSTAR-One, writes in this post in USAID's "Impact Blog."
FEI is pleased to announce that researchers at the NIH-FEI Living Lab for Structural Biology have achieved breakthrough biological results, using FEI's Titan Krios™ transmission electron microscope (TEM), to elucidate the structural mechanism by which glutamate receptors participate in the transmission of signals between neurons in the brain. Their work is described in Nature, "Structural Mechanism of Glutamate Receptor Activation and Desensitization," by Meyerson, et al., (DOI: 10.1038/nature13603), http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13603.html .
› Verified 9 days ago
| Entity Name | St Jude Childrens Research Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306335088 PECOS PAC ID: 7315133444 Enrollment ID: O20180821000139 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Left ventricular assist devices, or LVADs, have been shown to help leaky mitral valves that create significant regurgitation, but a new study questions the presumption that all's well with the mitral valve after a patient receives a LVAD.
"During the recent International XIX International AIDS Conference (AIDS 2012) in Washington, D.C., exciting breakthroughs in HIV prevention, treatment, and care - even a possible cure - took center stage," but, "despite recent advances, many men and women remain at risk of HIV as a result of structural issues that fuel and have an impact on the epidemic," Molly Fitzgerald, technical advisor for AIDSTAR-One, writes in this post in USAID's "Impact Blog."
FEI is pleased to announce that researchers at the NIH-FEI Living Lab for Structural Biology have achieved breakthrough biological results, using FEI's Titan Krios™ transmission electron microscope (TEM), to elucidate the structural mechanism by which glutamate receptors participate in the transmission of signals between neurons in the brain. Their work is described in Nature, "Structural Mechanism of Glutamate Receptor Activation and Desensitization," by Meyerson, et al., (DOI: 10.1038/nature13603), http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13603.html .
› Verified 9 days ago
| Entity Name | Wallace Plastic Surgery Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497473557 PECOS PAC ID: 0749664076 Enrollment ID: O20220905000477 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Left ventricular assist devices, or LVADs, have been shown to help leaky mitral valves that create significant regurgitation, but a new study questions the presumption that all's well with the mitral valve after a patient receives a LVAD.
"During the recent International XIX International AIDS Conference (AIDS 2012) in Washington, D.C., exciting breakthroughs in HIV prevention, treatment, and care - even a possible cure - took center stage," but, "despite recent advances, many men and women remain at risk of HIV as a result of structural issues that fuel and have an impact on the epidemic," Molly Fitzgerald, technical advisor for AIDSTAR-One, writes in this post in USAID's "Impact Blog."
FEI is pleased to announce that researchers at the NIH-FEI Living Lab for Structural Biology have achieved breakthrough biological results, using FEI's Titan Krios™ transmission electron microscope (TEM), to elucidate the structural mechanism by which glutamate receptors participate in the transmission of signals between neurons in the brain. Their work is described in Nature, "Structural Mechanism of Glutamate Receptor Activation and Desensitization," by Meyerson, et al., (DOI: 10.1038/nature13603), http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13603.html .
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert D Wallace, MD 1407 Union Ave Ste 700, Memphis, TN 38104-3641 Ph: (901) 866-8622 | Dr Robert D Wallace, MD 1068 Cresthaven Rd Ste 500, Memphis, TN 38119 Ph: (901) 866-8525 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Left ventricular assist devices, or LVADs, have been shown to help leaky mitral valves that create significant regurgitation, but a new study questions the presumption that all's well with the mitral valve after a patient receives a LVAD.
"During the recent International XIX International AIDS Conference (AIDS 2012) in Washington, D.C., exciting breakthroughs in HIV prevention, treatment, and care - even a possible cure - took center stage," but, "despite recent advances, many men and women remain at risk of HIV as a result of structural issues that fuel and have an impact on the epidemic," Molly Fitzgerald, technical advisor for AIDSTAR-One, writes in this post in USAID's "Impact Blog."
FEI is pleased to announce that researchers at the NIH-FEI Living Lab for Structural Biology have achieved breakthrough biological results, using FEI's Titan Krios™ transmission electron microscope (TEM), to elucidate the structural mechanism by which glutamate receptors participate in the transmission of signals between neurons in the brain. Their work is described in Nature, "Structural Mechanism of Glutamate Receptor Activation and Desensitization," by Meyerson, et al., (DOI: 10.1038/nature13603), http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13603.html .
› Verified 9 days ago
Leonard Harvey Hines, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 6005 Park Ave, Suite 821-b, Memphis, TN 38119 Phone: 901-726-1056 Fax: 901-726-5867 | |
William Leslie Hickerson, MD Surgery Medicare: Medicare Enrolled Practice Location: 890 Madison Ave, Suite Tg032, Memphis, TN 38103 Phone: 901-448-2579 Fax: 901-448-2602 | |
Dr. Albert Joseph Grobmyer Iii, Surgery Medicare: Not Enrolled in Medicare Practice Location: 3175 Lenox Park Blvd, Suite 309, Memphis, TN 38115 Phone: 901-273-2600 Fax: 901-761-3786 | |
Dr. Dan Huff Shell Iii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 200, Memphis, TN 38119 Phone: 901-761-4844 Fax: 901-761-6929 | |
Randall William Franz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave Ste 365, Memphis, TN 38104 Phone: 901-272-6018 Fax: 901-201-4203 | |
Dr. Christine T Mroz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 6005 Park, #700, Memphis, TN 38119 Phone: 901-527-3391 Fax: 901-578-3969 |